X0202 SCHEDULE 13G/A 0001172661-26-002217 0001583977 XXXXXXXX LIVE 1 American Depositary Shares, each representing three Class A Ordinary Shares 06/30/2026 0001944552 Adlai Nortye Ltd. 00704R109 c/o PO Box 309, Ugland House Grand Cayman E9 KY1-1104 Rule 13d-1(b) Cormorant Asset Management, LP b DE 0.00 3978229.00 0.00 3978229.00 3978229.00 N 6.77 IA PN Bihua Chen b X1 0.00 3978229.00 0.00 3978229.00 3978229.00 N 6.77 HC IN Adlai Nortye Ltd. c/o PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands Cormorant Asset Management, LP Bihua Chen This statement is filed by (i) Cormorant Asset Management, LP, a Delaware limited partnership, and the investment adviser to certain funds (the "Cormorant Funds"), with respect to the shares directly held by the Cormorant Funds and (ii) Bihua Chen with respect to the shares directly held by the Cormorant Funds. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the shares reported herein. 200 Clarendon Street, 50th Floor Boston, MA 02116 Cormorant Asset Management, LP - Delaware Bihua Chen - United States N IA HC 3,978,229 6.77% 0 3,978,229 0 3,978,229 The percentages reported herein with respect to the Reporting Persons' holdings are calculated based upon (i) a statement on Form 20-F filed by the Issuer on April 10, 2026 that there were 142,241,572 Class A ordinary shares outstanding as of April 10, 2026 and that one American Depositary Share represents three Class A Ordinary Shares and (ii) a statement in Exhibit No. 99.1 attached to the Current Report on Form 6-K filed by the Issuer on April 16, 2026 reporting that the Issuer was selling 11,320,755 American Depositary Shares in a private placement and that the private placement was expected to close on April 17, 2026. Y N See Item 2. The Cormorant Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares reported herein. Cormorant Global Healthcare Master Fund, LP, a Cormorant Fund, has the right to receive or the power to direct the receipt of dividends or the proceeds from the sale of more than 5% of the shares. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Joint Filing Statement, incorporated by reference to the Joint Filing Statement included with the Schedule 13G filed by the Reporting Persons on May 15, 2026. Cormorant Asset Management, LP /s/ Bihua Chen 08/14/2026 Bihua Chen /s/ Bihua Chen 08/14/2026